XGN Exagen Inc

USD 1.59 0.03 1.923077
Icon

Exagen Inc (XGN) Stock Analysis and Price Targets

COMMON STOCK | Diagnostics & Research | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 1.59

+0.03 (+1.92)%

USD 0.03B

0.03M

USD 5.00(+214.47%)

N/A

Icon

XGN

Exagen Inc (USD)
COMMON STOCK | NSD
USD 1.59
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.03B

N/A

USD 1.59

Exagen Inc (XGN) Stock Forecast

USD 5.00
(+214.47%)

Based on the Exagen Inc stock forecast from 1 analysts, the average analyst target price for Exagen Inc is USD 5.00 over the next 12 months. Exagen Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Exagen Inc is Bearish, which is based on 2 positive signals and 7 negative signals. At the last closing, Exagen Inc’s stock price was USD 1.59. Exagen Inc’s stock price has changed by -4.79% over the past week, -15.43% over the past month and -29.33% over the last year.

No recent analyst target price found for Exagen Inc
No recent average analyst rating found for Exagen Inc

Company Overview Exagen Inc

Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. The company enables healthcare providers to care for patients through the diagnosis, prognosis, and monit...Read More

https://www.exagen.com

1261 Liberty Way, Vista, CA, United States, 92081

199

December

USD

USA

Adjusted Closing Price for Exagen Inc (XGN)

Loading...

Unadjusted Closing Price for Exagen Inc (XGN)

Loading...

Share Trading Volume for Exagen Inc Shares

Loading...

Compare Performance of Exagen Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for XGN

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Exagen Inc (Sector: Diagnostics & Research )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
IDXX
IDEXX Laboratories Inc +0.36 (+0.07%) USD44.10B 52.65 36.72

ETFs Containing XGN

Symbol Name XGN's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Exagen Inc (XGN) Stock

Based on ratings from 1 analysts Exagen Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 1 buy, sell and hold ratings.

Unfortunately we do not have enough data on XGN's stock to indicate if its a good dividend stock.

Based on targets from 1 analysts, the average taret price for XGN is USD 5.00 over the next 12 months. The maximum analyst target price is USD 5 while the minimum anlayst target price is USD 5.

XGN stock's Price/Earning ratio is 0.38. Our analysis grades XGN stock's Price / Earning ratio at B+. This means that XGN stock's Price/Earning ratio is above 13% of the stocks in the Diagnostics & Research sector in the NSD exchange. Based on this XGN may be undervalued for its sector.

The last closing price of XGN's stock was USD 1.59.

The most recent market capitalization for XGN is USD 0.03B.

Based on targets from 1 analysts, the average taret price for XGN is projected at USD 5.00 over the next 12 months. This means that XGN's stock price may go up by +214.47% over the next 12 months.

We can't find any ETFs which contains Exagen Inc's stock.

As per our most recent records Exagen Inc has 199 Employees.

Exagen Inc's registered address is 1261 Liberty Way, Vista, CA, United States, 92081. You can get more information about it from Exagen Inc's website at https://www.exagen.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...